RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS

被引:2
|
作者
FitzGerald, O. [1 ,2 ]
Rubbert-Roth, A. [3 ]
Chen, K. [4 ]
Meerwein, S. [5 ]
Enejosa, J. [4 ]
Shaw, T. [4 ]
Wells, A. F. [6 ]
机构
[1] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland
[2] Univ Coll Dublin, Conway Inst, Dublin, Ireland
[3] Kantonsspital St Gallen, St Gallen, Switzerland
[4] AbbVie, N Chicago, IL USA
[5] AbbVie Deutschland, Ludwigshafen, Germany
[6] Rheum & Immunotherapy Ctr, Franklin, TN USA
关键词
D O I
10.1136/annrheumdis-2018-eular.4221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0239
引用
收藏
页码:981 / 981
页数:1
相关论文
共 50 条
  • [1] Rapid Response With Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A.
    SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [2] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    RHEUMATOLOGY, 2019, 58 : 65 - 65
  • [3] Rapid Response with Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
    FitzGerald, Oliver
    Rubbert-Roth, Andrea
    Chen, Kun
    Meenwein, Sebastian
    Enejosa, Jose Jeffrey
    Shaw, Tim
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
    FitzGerald, O.
    Rubbert-Roth, A.
    Chen, K.
    Meerwein, S.
    Enejosa, J.
    Shaw, T.
    Wells, A. F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S53 - S53
  • [5] ASSESSMENT OF THE RESPONSE TO THERAPY WITH CSDMARDS AND BDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Boyadzhieva, Vladimira
    Stoilov, Nikolay
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1573 - 1573
  • [6] CLINICAL RESPONSES IN PATIENTS WITH INADEQUATE RESPONSE TO BDMARDS UPON TREATMENT WITH UPADACITINIB
    Weinblatt, Michael
    Thomson, Glen
    Chen, Kun
    Meerwein, Sebastian
    Schlacher, Casey
    Cush, John
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 759 - 759
  • [7] Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib
    Weinblatt, Michael
    Thomson, Glen
    Chen, Kun
    Meerwein, Sebastian
    Schlacher, Casey
    Cush, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] A retrospective study of efficacy of tofacitinib combined with bDMARDs in the treatment of rheumatoid arthritis patients with inadequate response to bDMARDs
    Chang, Jie
    Wang, Gang
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (09)
  • [9] Long-Term Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to CsDMARDs: Results at 60 Weeks
    Burmester, Gerd
    Van den Bosch, Filip
    Bessette, Louis
    Kivitz, Alan
    Li, Yihan
    Friedman, Alan
    Pangan, Aileen
    Camp, Heidi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
    Kremer, Joel M.
    Schiff, Michael
    Muram, David
    Zhong, Jinglin
    Alam, Jahangir
    Genovese, Mark C.
    RMD OPEN, 2018, 4 (01):